2021 Revenues ($USD) : $17,000,000,000
2021 R&D spend : $872,000,000
2021 Number of Employees : 47,000
Fiscal Year End : 12/31/2020
Key People : Kieran Murphy, president and CEO; Helmut Zodl, VP and CFO; Katya Kruglova, VP, human resources; Michael McAlevey, VP, general counsel and business development; Jan Makela, president and CEO, imaging; Roland Rott, president and CEO, ultrasound; Thomas Westrick, president and CEO, life care solutions; Kevin O'Neill, president and CEO, pharmaceutical diagnostics; Amit Phadnis, VP and chief digital officer; Luiz Verzegnassi, president and CEO, services and GE Healthcare chief diversity officer; Everett Cunningham, president and CEO, U.S. and Canada; Catherine Estrampes, president and CEO, EMEA; Yihao Zhang, president and CEO, China; Rob Walton, president and CEO, ASEAN, Korea and ANZ; Soichiro Tada, president and CEO, Japan; Rafael Palombini, president and CEO, Latin America; Shravan Subramanyam, president and CEO, India and South Asia; Ian Dale, chief supply chain officer; Laila Gurney, chief quality and regulatory officer; Steve Laurent, chief information officer; Greg Gibbons, chief communications officer; Brian Montgomery, strategy leader; David Briggs, senior lean leader.

About the company: Incorporated in 1994, GE Healthcare remains one of the largest medical device manufacturers. In November 2021, the parent company announced its plans to split the conglomerate into three publicly traded companies focused on healthcare, aviation and energy, respectively. The company anticipates that it will complete the healthcare spinoff in 2023. Currently, GE Healthcare specializes in the development of imaging, mobile, diagnostic and monitoring devices. In 2021, the company announced its plan to acquire ultrasound technology company BK Medical for $1.45 billion. Subject to customary closing conditions, it would expand the company’s ultrasound platform to include several new applications. Like its parent company, GE Healthcare has a significant history. The foundation for the organization came in 1896 when Victor Electric Co. began producing components for X-ray tubes and electrotherapeutic devices. By 1920, General Electric decided to purchase Victor Electric to bolster its X-ray tube manufacturing capabilities. In the 1950s, GE created a dedicated medical systems division. The healthcare unit continued to diversify in the decades that followed. It began making CT machines in the 1970s. MRI machines and patient-monitoring systems would become a focus in the 1980s. Its emphasis on medical imaging and diagnostics continued to sharpen toward the end of the twentieth century, leading to the christening of the division as GE Healthcare in 1994. In the early 2000s, the organization continued to grow thanks to a string of acquisitions. In 2018, the parent company had proposed making GE Healthcare a standalone company, but GE ultimately decided to sell a biopharma division to Danaher for $21.4 billion instead. That same year, GE Healthcare unloaded a number of healthcare information technology assets to Veritas Capital for $1.05 billion. ​​Peter Arduini is in the process of leaving the top spot at Integra Lifesciences to become GE Healthcare’s CEO effective Jan. 1, 2022. —BB